Ophthalmologic Approach to Chemical Burns Follow-up

  • Author: J Bradley Randleman, MD; Chief Editor: Hampton Roy Sr, MD   more...
 
Updated: Feb 7, 2011
 

Further Inpatient Care

  • In patients with severe chemical injuries, short hospitalization may be warranted to closely monitor IOP, corneal integrity, medication use, and pain control.
Next

Further Outpatient Care

  • Close follow-up care is mandatory in the first weeks following a severe chemical injury to assess epithelial regeneration and corneal melting, to change medications, to control inflammation and IOP, and to prevent secondary infection. Patients should be under the care of an ophthalmologist during this critical period.
Previous
Next

Inpatient & Outpatient Medications

  • Prednisolone acetate 1% (1 gtt qid)
  • Erythromycin ophthalmic ointment (4-8 times/d)
  • Homatropine 5% or scopolamine 0.25% (1 gtt tid)
  • Ascorbate (500 mg PO qid)
  • Levobunolol hydrochloride 0.5% (1 gtt bid) or acetazolamide (500 mg PO bid) - Pressure lowering agents, such as levobunolol and acetazolamide, are only indicated if IOP is increased (>30 mm Hg).
Previous
Next

Transfer

  • After completing initial irrigation and treatment, patients should be transferred to facilities that have ophthalmologists available to assume care for them.
Previous
Next

Deterrence/Prevention

  • Education and training regarding the prevention of chemical exposures in the workplace can help prevent chemical injuries to the eye.
  • Persons who may be exposed to chemicals in the workplace are advised to wear safety goggles.
Previous
Next

Complications

Primary complications include the following:

  • Conjunctival inflammation
  • Corneal haze and edema
  • Acute rise in IOP
  • Corneal melting and perforations

Secondary complications include the following:

  • Secondary glaucoma
  • Secondary cataract
  • Conjunctival scarring
  • Corneal thinning and perforation
  • Complete ocular surface disruption with corneal scarring and vascularization
  • Corneal ulceration (sterile or infectious)
  • Complete globe atrophy (phthisis bulbi): See the image below.Complete cicatrization of the corneal surface follComplete cicatrization of the corneal surface following chemical injury.
Previous
Next

Prognosis

In general, the prognosis of ocular chemical injuries is directly correlated with the severity of insult to the eye and adnexal structures.

Many classification systems and revisions thereof have been aimed at classifying ocular burns in relation to their prognosis, including the following systems: Hughes, Roper-Hall, and Pfister.[9] In essence, all systems aim to quantify the degree of corneal epithelial involvement, the degree of limbal stem cell loss, and the degree of conjunctival involvement.[16]

Injuries can be graded from 0-5, as follows:

  • Grade 0 - Minimal epithelial defect, clear corneal stroma, no limbal ischemia
  • Grade 1 - Partial-complete epithelial defect, clear corneal stroma, no limbal ischemia
  • Grade 2 - Partial-complete epithelial defect, mild stromal haze, none or only mild limbal ischemia
  • Grade 3 - Complete epithelial defect, moderate stromal haze, less than one third of the limbus is ischemic
  • Grade 4 - Complete epithelial defect, stromal haze blurring iris details, one third to two thirds of the limbus is ischemic
  • Grade 5 - Complete epithelial defect, stromal opacification, greater than two thirds of the limbus is ischemic

Grades 0-2 can be expected to heal well with proper care and follow-up examinations.

The course for grades 3-5 is more tenuous and may require surgical intervention, either limbal stem cell transplantation or penetrating keratoplasty, to regenerate the corneal surface.

Higher-grade injuries are more susceptible to secondary complications.

Previous
Next

Patient Education

  • If the injury resulted from a preventable accident, proper safety instruction should be provided.
  • If a patient is left functionally monocular from an injury, the patient should be instructed in the use of safety eyewear (eg, polycarbonate lenses).
  • For excellent patient education resources, visit eMedicine's Burns Center and Eye and Vision Center. Also, see eMedicine's patient education articles Chemical Burns, Chemical Eye Burns, and Eye Injuries.
Previous
 
Contributor Information and Disclosures
Author

J Bradley Randleman, MD  Associate Professor, Department of Ophthalmology, Section of Cornea, External Disease and Refractive Surgery, Emory University School of Medicine; Director of Cornea, External Disease and Refractive Surgery Fellowship, Emory University; Physician Member, Section of Ophthalmology, The Emory Clinic

J Bradley Randleman, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Cornea Society, and International Society of Refractive Surgery

Disclosure: Nothing to disclose.

Coauthor(s)

Alok S Bansal, MD  Resident Physician, Emory Eye Center

Alok S Bansal, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Association for Research in Vision and Ophthalmology, and International Society of Refractive Surgery

Disclosure: Nothing to disclose.

Evan S Loft  MD, Clinical Assistant Professor, Department of Ophthalmology, Emory University

Evan S Loft is a member of the following medical societies: American Academy of Ophthalmology, American Medical Association, American Society of Cataract and Refractive Surgery, Association for Research in Vision and Ophthalmology, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Geoffrey Broocker, FACS, MD  Walthour-DeLaPerriere Professor of Ophthalmology, Department of Ophthalmology, Emory University School of MedicineChief of Service, Ophthalmology, Grady Memorial Hospital

Geoffrey Broocker, FACS, MD is a member of the following medical societies: American College of Surgeons

Disclosure: Nothing to disclose.

Specialty Editor Board

Fernando H Murillo-Lopez, MD  Senior Surgeon, Unidad Privada de Oftalmologia CEMES

Fernando H Murillo-Lopez, MD is a member of the following medical societies: American Academy of Ophthalmology

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD  Associate Professor of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology

Disclosure: Nothing to disclose.

Christopher J Rapuano, MD  Professor, Department of Ophthalmology, Jefferson Medical College of Thomas Jefferson University; Director of the Cornea Service, Co-Director of Refractive Surgery Department, Wills Eye Institute

Christopher J Rapuano, MD is a member of the following medical societies: American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Contact Lens Association of Ophthalmologists, Cornea Society, Eye Bank Association of America, International Society of Refractive Surgery, and Pan-American Association of Ophthalmology

Disclosure: Allergan Honoraria Speaking and teaching; Allergan Consulting fee Consulting; Alcon Honoraria Speaking and teaching; Inspire Honoraria Speaking and teaching; RPS Ownership interest Other; Vistakon Honoraria Speaking and teaching; EyeGate Pharma Consulting; Inspire Consulting fee Consulting; Bausch & Lomb Honoraria Speaking and teaching; Bausch & Lomb Consulting fee Consulting

Lance L Brown, OD, MD  Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri

Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD  Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences

Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology

Disclosure: Nothing to disclose.

References
  1. Merle H, Gerard M, Schrage N. [Ocular burns]. J Fr Ophtalmol. Sep 2008;31(7):723-34. [Medline].

  2. Hodge C, Lawless M. Ocular emergencies. Aust Fam Physician. Jul 2008;37(7):506-9. [Medline].

  3. Spector J, Fernandez WG. Chemical, thermal, and biological ocular exposures. Emerg Med Clin North Am. Feb 2008;26(1):125-36, vii. [Medline].

  4. Pfister DA, Pfister RR. Acid injuries of the eye. Fundamentals of Cornea and External Disease. Cornea. Vol 2. 2005:1277-84.

  5. Pfister RR, Pfister DA. Alkali injuries of the eye. In: Fundamentals of Cornea and External Disease. Cornea. Vol 2. 2005:1285-93.

  6. Xiang H, Stallones L, Chen G, Smith GA. Work-related eye injuries treated in hospital emergency departments in the US. Am J Ind Med. Jul 2005;48(1):57-62. [Medline].

  7. Morgan SJ. Chemical burns of the eye: causes and management. Br J Ophthalmol. Nov 1987;71(11):854-7. [Medline].

  8. Klein R, Lobes LA Jr. Ocular alkali burns in a large urban area. Ann Ophthalmol. Oct 1976;8(10):1185-9. [Medline].

  9. Wagoner MD, Kenyon KR. Chemical injuries of the eye. Clinical Practice. In: Albert, Jakobiec, eds. Principles and Practice of Ophthalmology. Vol 2. 2000:943-59.

  10. Kheirkhah A, Johnson DA, Paranjpe DR, Raju VK, Casas V, Tseng SC. Temporary sutureless amniotic membrane patch for acute alkaline burns. Arch Ophthalmol. Aug 2008;126(8):1059-66. [Medline].

  11. Tandon R, Gupta N, Kalaivani M, et al. Amniotic membrane transplantation as an adjunct to medical therapy in acute ocular burns. Br J Ophthalmol. Feb 2011;95(2):199-204. [Medline].

  12. Brodovsky SC, McCarty CA, Snibson G, et al. Management of alkali burns : an 11-year retrospective review. Ophthalmology. Oct 2000;107(10):1829-35. [Medline].

  13. Kheirkhah A, Johnson DA, Paranjpe DR, Raju VK, Casas V, Tseng SC. Temporary sutureless amniotic membrane patch for acute alkaline burns. Arch Ophthalmol. Aug 2008;126(8):1059-66. [Medline].

  14. Kawashima M, Kawakita T, Satake Y, Higa K, Shimazaki J. Phenotypic study after cultivated limbal epithelial transplantation for limbal stem cell deficiency. Arch Ophthalmol. Oct 2007;125(10):1337-44. [Medline].

  15. Tuft SJ, Shortt AJ. Surgical rehabilitation following severe ocular burns. Eye. Jan 23 2009;[Medline].

  16. Dua HS, King AJ, Joseph A. A new classification of ocular surface burns. Br J Ophthalmol. Nov 2001;85(11):1379-83. [Medline].

Previous
Next
 
Alkali burn. Note the severe conjunctival reaction and stromal opacification blurring iris details inferiorly.
Severe chemical injury with early corneal neovascularization.
Complete cicatrization of the corneal surface following chemical injury.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.